Cure GM1 Foundation’s Post

We are pleased to welcome Paul to the team! BIO: Paul Fitzpatrick has nearly 30 years of biotechnology leadership experience including an impactful 20-year career at BioMarin, where he led the Biologics and Production Group, including scientific and operational responsibility for research stage biologics (ERTs) and AAV production, as well as early stage process analytics and structural, cellular, and protein biology fundamental research. Since then, Paul has worked at Zogenix, Inc. and Chameleon, Inc. doing further CMC and research work in AAV gene therapy. He now works as an independent consultant. Paul earned a Ph.D. in applied biochemistry from the Massachusetts Institute of Technology and Bachelor of Science degrees in both biology and chemistry from UC Irvine. #curegm1 #raredisease #hope #community #science

Monica Miller, MS, Ed.D.

Executive Leadership in Strategic Planning | Program/Asset Development | Start Up Operations Strategy| Alliance + Portfolio + Program Management | Effective Teamwork

1w

Great news! Paul is top notch and has a lot to contribute.

Emil Kakkis

Chief Executive Officer and President at Ultragenyx Pharmaceutical Inc.

6d

Paul is a great scientist and will be a great help having worked on treatments for multiple lysosomal diseases.

Sean Bell

BioPharma Professional / Biologics Consultant @ Bell BioPharma Consulting, LLC / MBA candidate

1w

Congratulations! I hope you are doing well.

Rajeev Mahimkar

AAV Gene Therapy | Rare-Orphan Disorders | Sloan Fellow London Business School

1w

Congratulations Paul Fitzpatrick

Terri Christianson

Director/Group Leader/Biologics/Gene Therapy Production Research and Early Development

1w

Congratulations Paul!

Bin Zhao

Site Head of US Bioanalytical Lab | GLP, Ligand Binding Assays

1w

Congratulations Paul!

Nicolina (Nikki) Hull-Campbell

Strategic Portfolio, Program and Alliance Management, PMP

1w

Congratulations Paul!

Jun Miao

Director, Gene Therapy Pilot Plant at BioMarin Pharmaceutical Inc.

1w

Congratulations, Paul!

Vanessa Rangel Miller

Molecular Diagnostics Programs at Ultragenyx Pharmaceutical Inc.

1w

Terrific!

See more comments

To view or add a comment, sign in

Explore topics